Bridging the Digital Divide to Advance Bio/Pharma Manufacturing and Quality: A Technology Forum

Published on: May 25, 2021

Webcast

*Tuesday, May 25, 2021 at 10am EDT* The bio/pharma industry is turning to proven digital technologies used in other industries to plan, develop, and monitor manufacturing processes, as well as in quality, training, and regulatory oversight. In this event, experts discuss how artificial intelligence, remote monitoring, digital twins, and other technologies can be applied to modernize bio/pharma processes and systems. Lessons learned from the pandemic will be shared. *On Demand Until May 25, 2022*

Register free: https://www.pharmtech.com/pt_w/interphex2

Event Overview:

The bio/pharma industry is turning to proven digital technologies used in other industries to plan, develop, and monitor manufacturing processes, as well as in quality, training, and regulatory oversight. In this event, experts discuss how artificial intelligence, remote monitoring, digital twins, and other technologies can be applied to modernize bio/pharma processes and systems. Lessons learned from the pandemic will be shared.

Agenda:

Session 1 - 10-11:15am EDT

Digitalization: Moving from Theory to Practice

The use of digital technologies for bio/pharmaceutical process development, manufacturing, quality control, and general operations sounds promising. What are the challenges in putting these innovations into practice in a regulated environment? Experts will share insights and experience in moving digital concepts into practice.

What bio/pharma can learn from practices in other industries
Improving product quality with digital tools for the lab and manufacturing facility
The role of AI, analytics, and digital twins in the facility of the future
Remote auditing pitfalls and best practices
Using virtual inspection tools for evaluating vendors and manufacturing facilities

Panelists:

Evgeniya Makarova, partner, McKinsey & Company
Ulf Schrader, senior partner, McKinsey & Company
Peter Miller, principal partner, Dynamic Compliance Solutions
Chris Alden, associate director, global CGMP auditing and compliance, Merck

Session 2 - 11:20am-1pm EDT